Amedisys, Inc.
AMED
$100.99
$0.0050.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.40B | 2.37B | 2.35B | 2.32B | 2.29B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.40B | 2.37B | 2.35B | 2.32B | 2.29B |
| Cost of Revenue | 1.36B | 1.34B | 1.33B | 1.31B | 1.28B |
| Gross Profit | 1.04B | 1.03B | 1.02B | 1.01B | 1.01B |
| SG&A Expenses | 793.48M | 792.95M | 790.11M | 787.11M | 781.75M |
| Depreciation & Amortization | 18.16M | 18.17M | 18.00M | 17.57M | 17.24M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.18B | 2.15B | 2.14B | 2.11B | 2.08B |
| Operating Income | 226.03M | 217.41M | 209.57M | 208.93M | 209.12M |
| Income Before Tax | 149.29M | 150.19M | 86.22M | 134.64M | 143.60M |
| Income Tax Expenses | 67.42M | 64.81M | 48.05M | 51.94M | 51.80M |
| Earnings from Continuing Operations | 81.87 | 85.39 | 38.16 | 82.70 | 91.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.76M | 4.45M | 5.07M | 233.00K | 180.00K |
| Net Income | 85.63M | 89.84M | 43.23M | 82.93M | 91.98M |
| EBIT | 226.03M | 217.41M | 209.57M | 208.93M | 209.12M |
| EBITDA | 253.06M | 244.10M | 235.61M | 234.15M | 233.57M |
| EPS Basic | 2.61 | 2.74 | 1.32 | 2.54 | 2.82 |
| Normalized Basic EPS | 4.45 | 4.21 | 4.00 | 3.74 | 3.69 |
| EPS Diluted | 2.57 | 2.71 | 1.31 | 2.51 | 2.79 |
| Normalized Diluted EPS | 4.41 | 4.17 | 3.97 | 3.71 | 3.66 |
| Average Basic Shares Outstanding | 131.14M | 131.00M | 130.87M | 130.76M | 130.64M |
| Average Diluted Shares Outstanding | 132.39M | 132.15M | 131.91M | 132.07M | 131.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |